申请人:WARNER-LAMBERT COMPANY
公开号:EP0186367A2
公开(公告)日:1986-07-02
There are disclosed compounds having the following general formula (I):
and pharmaceutically acceptable salts thereof, wherein:
R' and Q are each, independently, H, an alkyl having from one to twelve carbon atoms, an alkoxy having from one to twelve carbon atoms, mercapto. an alkylthio having from one to four carbon atoms, an alkylsulphinyl having from one to four carbon atoms, an alkylsulphonyl having from one to four carbon atoms, a hydroxy group, a nitro group, an amino group, substituted amino group or a halogen, R' being further chosen from a methylenedioxy radical attached to adjacent carbon atoms of the benzene ring;
R2 is H, an alkyl having from one to twelve carbon atoms, a phenyl radical, a substituted phenyl radical or a benzyl radical;
R3 is H, an alkyl having from one to twelve carbon atoms, an alkoxy having from one to twelve carbon atoms, mercapto, an alkylthio having from one to four carbon atoms, a phenylthio radical, a substituted phenylthio radical, an alkylsulphinyl having from one to four carbon atoms, a phenylsulphinyl radical, a substituted phenylsulphinyl radical, an alkylsulphonyl hving from one to four carbon atoms, a phenylsolphonyl radical, a substituted phenylsolphonyl radical an amino group, or a substitued amino group; and
R4 is
Methods of preparing the compounds, compositions comprising the compounds and the pharmaceutical use of the compounds are also disclosed.
公开了具有以下通式(I)的化合物:
及其药学上可接受的盐类,其中
R'和 Q 各自独立地为 H、1-12 个碳原子的烷基、1-12 个碳原子的烷氧基、1-4 个碳原子的巯基、1-4 个碳原子的烷硫基、1-4 个碳原子的烷基亚磺酰基、1-4 个碳原子的烷基磺酰基、羟基、硝基、氨基、取代氨基或卤素,R'可进一步选自连接到苯环相邻碳原子上的亚甲二氧基;
R2 是 H、具有 1 至 12 个碳原子的烷基、苯基、取代苯基或苄基;
R3 是 H、具有一至十二个碳原子的烷基、具有一至十二个碳原子的烷氧基、巯基、具有一至四个碳原子的烷硫基、苯硫基、取代的苯硫基、具有一至四个碳原子的烷基亚磺酰基、一个氨基或一个取代氨基;和
R4 是
还公开了制备这些化合物的方法、包含这些化合物的组合物以及这些化合物的药物用途。